IL33 and rheumatoid arthritis: Genetic dysregulation of the IL-33/ST2 axis significantly increases the predisposition toward development of inflammatory bowel disease, systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus (30, 32–35).